Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma (Q34034292)

30 July 2017

title

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma (English)

1 reference

stem cell transplantation

30 July 2017

main subject

1 reference

1 reference

Parameswaran N Hari

2

0 references

Koen van Besien

object named as

Koen van Besien

26

0 references

Robert Peter Gale

11

object named as

Robert Peter Gale

1 reference

30 July 2017

27

Hillard M Lazarus

1 reference

30 July 2017

28

Julie M Vose

1 reference

30 July 2017

23

Peter H Wiernik

1 reference

30 July 2017

8

Richard E Champlin

1 reference

30 July 2017

12

Gregory A Hale

1 reference

30 July 2017

6

Brian J Bolwell

1 reference

30 July 2017

3

Jeanette Carreras

1 reference

30 July 2017

7

Mitchell S Cairo

1 reference

30 July 2017

1

Timothy S Fenske

1 reference

30 July 2017

5

Rammurti T Kamble

1 reference

30 July 2017

16

Dipnarine Maharaj

1 reference

30 July 2017

18

Reinhold Munker

1 reference

30 July 2017

20

Philip A Rowlings

1 reference

30 July 2017

10

César O Freytes

1 reference

30 July 2017

22

Patrick Stiff

1 reference

30 July 2017

25

J Douglas Rizzo

1 reference

30 July 2017

13

Osman Ilhan

1 reference

30 July 2017

Mei-Jie Zhang

4

1 reference

30 July 2017

Yi-Bin Chen

9

1 reference

30 July 2017

H Jean Khoury

14

1 reference

30 July 2017

John Lister

15

1 reference

30 July 2017

David I Marks

17

1 reference

30 July 2017

Andrew L Pecora

19

1 reference

30 July 2017

Thomas C Shea

21

1 reference

30 July 2017

Jane N Winter

24

1 reference

30 July 2017

publication date

1 November 2009

1 reference

Biology of Blood and Marrow Transplantation

30 July 2017

published in

1 reference

30 July 2017

volume

15

1 reference

30 July 2017

issue

11

1 reference

30 July 2017

page(s)

1455-1464

1 reference

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Delayed-onset grade 4 neutropenia associated with rituximab therapy in a patient with lymphoma: case report and literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2913553

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

29 October 2018

1 reference

12 December 2020

Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL st

1 reference

12 December 2020

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

1 reference

12 December 2020

Delayed-onset neutropenia associated with rituximab therapy

1 reference

12 December 2020

10.1016/J.BBMT.2009.07.017

Identifiers

DOI

1 reference

release_brkahrjtx5cjrath2a76crvhqe

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/brkahrjtx5cjrath2a76crvhqe

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2913553

1 reference

30 July 2017

1 reference